Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride | Patent Number 07834020

US 07834020 B2
Application Number12110704
Publication NumberUS 20090023749 A1
Pendency2 years, 6 months, 22 days
Filled DateApr 28, 2008
Priority DateJun 5, 2002
Publication DateJan 22, 2009
Expiration DateJun 5, 2022
Inventor/ApplicantsAndreas Bathe
Susanne Rudolph
Henning Böttcher
Matthias Bartels
Steffen Neuenfeld
Heike Kniel
Bernd Helfert
Henning Bottcher
ExaminesBARKER, MICHAEL P
Art Unit1626
Technology Center1600
Assignments
Merck Patentgesellschaft
Current
Merck Patent Gesellschaft Mit Beschrankter HaftungMerck & Co. Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.